The Multi-Center Clinical Study of Tang Shen Prescription on Type 2 Diabetic Kidney Disease in Early Stage
Status:
Unknown status
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blinded, placebo-controlled clinical trial on type 2
diabetic Kidney Disease in early stage ( microalbuminuria excretion rate = 20-200mg/min) to
evaluate the therapeutic effect of tang shen prescription. 632 participants will be recruited
for the study, all of whom had type 2 diabetes, serum creatinine concentrations is normal,
and no evidence of non-diabetic renal diseases. The subjects will be randomized to treatment
with either tang shen prescription or placebo.
Phase:
Early Phase 1
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborators:
Anhui Provincial Hospital of Traditional Chinese Medicine Baishi Hospital Baoding City Hospital of Traditional Chinese Medicine Beijing Hospital of TCM Changchun Hospital of Traditional Chinese Medicine Hubei Hospital of Traditional Chinese Medicine Medicine Zibo Wanjie Tumor Hospital She Country Hospital of Traditional Chinese Medicine Shijiazhuang City Hospital of Traditional Chinese Medicine The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine Xingtai City Hospital of Traditional Chinese Medicine Zhengzhou City Hospital of Traditional Chinese Medicine Zouping Country Hospital of Traditional Chinese Medicine